At this time, I would like to welcome everyone to the DaVita first-quarter 2025 earnings call. (Operator Instructions) Mr. Eliason, you may begin your conference, sir. Thank you, and welcome to ...

Revenue: US$3.22b (up 5.0% from 1Q 2024). Net income: US$162.9m (down 32% from 1Q 2024). Profit margin: 5.1% (down from 7.8% in 1Q 2024). The decrease in margin was driven by higher expenses. EPS ...

DaVita Inc. DVA delivered adjusted earnings per share (EPS) of $2.00 in the first quarter of 2025, down 11.5% year over year. However, the figure surpassed the Zacks Consensus Estimate by 14.3% ...

In this article, we are going to take a look at where DaVita Inc. (NYSE:DVA) stands against other small-cap healthcare stocks hedge funds are buying. The U.S. healthcare sector has performed ...

DaVita Inc. (DVA), headquartered in Denver, Colorado, provides kidney dialysis services for patients suffering from chronic kidney failure. Valued at $11 billion by market cap, the company ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...